| Name: | Erlotinib Chloro Impurity |
| Catalogue No. | VL2460005 |
| CAS No. | 183322-18-1 |
| Molecular Formula | C14H17ClN2O4 |
| Molecular Weight | 312.75 |
| Status | In-stock |
| IUPAC Name | 4-chloro-6,7-bis(2-methoxyethoxy)quinazoline |
| Description | Erlotinib Chloro Impurity (CAS No.183322-18-1) or 4-chloro-6,7-bis(2-methoxyethoxy)quinazoline. Erlotinib is a oral low molecular weight quinazoline which selectively and reversibly inhibit Tyrosine Kinase(TK). It is specific epidermal growth factor receptor. |
| References | Pérez-Soler, Román, et al. "Determinants of tumor response and survival with erlotinib in patients with non—small-cell lung cancer." Journal of clinical oncology 22.16 (2004): 3238-3247. Bareschino, M. A., et al. “Erlotinib in Cancer Treatment.” Annals of Oncology, vol. 18, June 2007, pp. vi35–41, https://doi.org/10.1093/annonc/mdm222. |
